| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcus Biosciences, Inc. (RCUS) has 7 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. RCUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.16M | $58.75M | - | |
| Pres | 922.3K | $25.12M | - | |
| COO | 193.0K | $5.26M | - | |
| Other | 124.7K | $3.40M | - | |
| CFO | 67.9K | $1.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2018 | Jaen Juan C.75 | President | Buy | 66,666 | $15.00 | $999,990.00 | +2.5% | |
| Mar 19, 2018 | Rosen Terry J72 | Chief Executive Officer | Buy | 66,666 | $15.00 | $999,990.00 | +1.7% | |
| Mar 19, 2018 | Falberg Kathryn E53 | Director | Buy | 30,000 | $15.00 | $450,000.00 | +59.4% |